You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunoglobulin Idiotypes

Showing 1 - 25 of 843
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MRD Detection by NGS in Pediatric B-ALL

Completed
  • Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
  • MRD
  • Hangzhou, Zhejiang, China
    The Children's Hospital of Zhejiang University School of Medicin
Jul 25, 2023

Immunoglobulin E-Mediated Food Allergy, Immunoglobulin G4-Related Disease, Symptoms and Signs Trial in Madrid (Food-specific

Recruiting
  • Immunoglobulin E-Mediated Food Allergy
  • +3 more
  • Food-specific Immunoglobulin G4 and/or Immunoglobulin E antibody reactions
  • Madrid, Spain
    Universidad Politécnica de Madrid
Jan 3, 2023

Lymphoma Trial in Seattle (biological, other, procedure)

Not yet recruiting
  • Lymphoma
  • Immune Globulin Infusion (Human), 10% Solution
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 21, 2023

Covid-19 Patients Trial in Giza (Cupping therapy with convential medical treatment, Convential medical treatment)

Completed
  • Covid-19 Patients
  • Cupping therapy with convential medical treatment
  • Convential medical treatment
  • Giza, Egypt
    Faculty of physical therapy
Jun 11, 2023

CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune

Recruiting
  • CIDP
  • +2 more
  • Intravenous immune globulin G
  • Subcutaneous immune globulin G
  • New Brunswick, New Jersey
    Rutgers, The State University of New Jersey Clinical Research Ce
Oct 13, 2022

Allergy to Shrimp, Immunotherapy Trial in Bangkoknoi (shrimp allergy with intend to eat shrimp)

Recruiting
  • Allergy to Shrimp
  • Immunotherapy
  • shrimp allergy with intend to eat shrimp
  • Bangkoknoi, Bangkok, Thailand
    Siriraj Hospital
Sep 11, 2022

At-Home Subcutaneous Immunoglobulin Replacement Therapy Using

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • No Intervention
  • (no location specified)
Nov 21, 2023

Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in

Recruiting
  • Polyclonal Hypergammaglobulinemia
  • Autoimmune Diseases
    • Amiens, France
      CHU Amiens
    Sep 28, 2023

    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Australia, Canada,

    Completed
    Has Results
    • Localized Resectable Neuroblastoma
    • +4 more
    • Clinical Observation
    • +5 more
    • Birmingham, Alabama
    • +103 more
    Jan 4, 2023

    Primary Immunodeficiency Diseases (PID) Trial (TAK-881, HYQVIA)

    Not yet recruiting
    • Primary Immunodeficiency Diseases (PID)
    • TAK-881
    • HYQVIA
    • (no location specified)
    Feb 23, 2023

    Metropolitan Area of Buenos Aires

    Not yet recruiting
    • Dengue
    • Flavivirus Infections
    • Dengue Immunoglobulin G antibodies performed with ELISA
    • (no location specified)
    Jun 21, 2023

    Cervical Cancer Trial in Worldwide (AGEN1884 + AGEN2034)

    Completed
    • Cervical Cancer
    • AGEN1884 + AGEN2034
    • Goodyear, Arizona
    • +46 more
    Nov 2, 2022

    Advanced Solid Malignancies Trial in Irving (GIM122)

    Not yet recruiting
    • Advanced Solid Malignancies
    • Irving, Texas
      NEXT Dallas
    Sep 8, 2023

    IgA Nephropathy Trial (CM338)

    Not yet recruiting
    • IgA Nephropathy
    • CM338
    • (no location specified)
    Mar 7, 2023

    Burn Shock Trial in Cairo (intravenous immunoglobulin)

    Completed
    • Burn Shock
    • intravenous immunoglobulin
    • Cairo, Egypt
      Cairo University
    Nov 13, 2022

    NSCLC, Solid Tumor Trial in Tianjin (HS-20117)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Solid Tumor
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 10, 2023

    Food-specific IgG4-guided Elimination Diets Improve Allergy

    Completed
    • Rhinitis, Allergic
    • +4 more
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital，School of Medicine，Zhejiang Universit
      Sep 25, 2023

      Kawasaki Disease Trial in China (IVIG, Aspirin, Prednisolone)

      Recruiting
      • Kawasaki Disease
      • Beijing, China
      • +14 more
      Jan 9, 2023

      Proliferative Glomerulonephritis With Monoclonal IgG Deposits Trial in Rochester (Daratumumab)

      Not yet recruiting
      • Proliferative Glomerulonephritis With Monoclonal IgG Deposits
      • Rochester, Minnesota
        Mayo Clinic Minnesota
      Dec 8, 2022

      Tetanus Trial in China (TNM002 (low dose), TNM002 (medium dose), TNM002 (high dose))

      Completed
      • Tetanus
      • TNM002 (low dose)
      • +4 more
      • Shantou, Guangdong, China
      • +3 more
      Nov 20, 2022

      Decay, Dental, Missing Teeth, COVID-19 Trial in Ankara, Izmir, Izmir (ELISA test for Cytokines)

      Recruiting
      • Decay, Dental
      • +3 more
      • ELISA test for Cytokines
      • Ankara, Turkey
      • +3 more
      Jul 26, 2022

      Asthma Trial in Hangzhou (JYB1904, Omalizumab, JYB1904 Placebo)

      Active, not recruiting
      • Asthma
      • Hangzhou, Zhejiang, China
        Shulan (Hangzhou) Hospital
      Oct 23, 2022

      Determine Immunoglobulin G4 Standards for Cow's Milk and Egg in

      Recruiting
      • Food Allergy in Children
      • Blood collection
      • Paris, France
        Hôpital Necker Enfants malades
      Nov 7, 2022

      Guillain-Barre Syndrome Trial in Zhengzhou (immunosorbent column, intravenous immunoglobulin)

      Not yet recruiting
      • Guillain-Barre Syndrome
      • immunosorbent column
      • intravenous immunoglobulin
      • Zhengzhou, Henan, China
        First Affiliated Hospital of Zhengzhou University
      Oct 6, 2022

      Haematological Malignancy, Hypogammaglobulinemia Trial (trimethoprim-sulfamethoxazole (co-trimoxazole), amoxycillin/clavulanic

      Not yet recruiting
      • Haematological Malignancy
      • Hypogammaglobulinemia
      • trimethoprim-sulfamethoxazole (co-trimoxazole)
      • +2 more
      • (no location specified)
      Jan 4, 2023